| 週次 |
授課內容 |
| 第1週 |
1.0 Introduction of Tissue Engineering
1.1 General Overview, Goals, and Applications of Tissue Engineering |
| 第2週 |
2.0 Basic Principles of Cell Culture
2.1 Types of Cell Culture
2.2 Isolation of Cells for Culture
2.3 Subculture
2.4 Cryopreservation
2.5 Characterization and Validation |
| 第3週 |
3.0 Mesenchymal Stem Cells for Tissue Engineering
3.1 Background and Logic
3.2 Preparation of Media and Reagents
3.3 Isolation of Human Marrow-Derived Mesenchymal Stem Cells (HMSCS)
3.4 Propagation of Mesenchymal Stem Cells
3.5 Cryopreservation and Thawing of HMSCS |
| 第4週 |
4.0 Human Embryonic Stem Cell Culture for Tissue Engineering
4.1 Embryonic Stem Cells
4.2 Maintenance and Expansion of Human Embryonic Stem (HES) Cells
4.3 Induction of Differentiation in ES Cells
4.4 Isolation of Specific Cell Types from Cultures Originating from ES Cells
4.5 Scale-Up of ES Cells in Tissue Engineering
4.6 Protocols for Using ES Cells in Tissue Engineering |
| 第5週 |
5.0 Tissue Engineering: Basic Considerations
5.1 Introduction
5.2 In vitro Cultivation of Engineered Tissues
5.3 Overview of Cell Sources
5.4 Media
5.5 Biomaterial Scaffolds
5.6 Cellular Photoencapsulation in Hydrogels
5.7 Bioreactors
5.8 Scaffold Seeding
5.9 Bioreactor Cultivation
5.10 Engineered Tissue Analysis |
| 第6週 |
6.0 Cell Sources for Cartilage Tissue Engineering
6.1 Introduction
6.2 Preparation of Media and Reagents
6.3 Articular Chondrocytes for Cartilage Tissue Engineering
6.4 Cells with Chondrogenic Differentiation Potential
6.5 Chondrogenesis of Progenitor Cells in Vitro
6.6 Tissue Engineering Cartilage Implants from Cells with Chondrogenic Potential
6.7 Lipid-Mediated Gene Transfer for Cartilage Tissue Engineering |
| 第7週 |
7.0 Tissue Engineering of Articular Cartilage
7.1 Culture Conditions for Chondrocytes
7.2 Harvesting Cartilage and Isolation of Chondrocytes
7.3 Culture of Chondrocytes and Fabrication of Cartilaginous Tissue by the Scaffold-Free
7.4 Criteria for Evaluation of Cartilaginous Tissue Formation |
| 第8週 |
Midterm Oral Presentation |
| 第9週 |
Midterm Oral Presentation |
| 第10週 |
9.0 Tissue Engineering Human Skeletal Muscle for Clinical Applications
9.1 Introduction
9.2 Skeletal Muscle Needle Biopsy
9.3 Isolation and Culture of Human Skeletal Myoblasts |
| 第11週 |
9.4 Characterization of Human Skeletal Myoblasts
9.5 Tissue Engineering of Human Skeletal Myoblasts with Clinically Approved Extracellular Matrix Materials
9.6 Applications of Tissue-Engineered Human Skeletal Muscle |
| 第12週 |
10.0 Engineered Heart Tissue (EHT)
10.1 Background of EHT
10.2 Isolation and Culture Methodology
10.3 Gene Transfer in Engineered Heart Tissue
10.4 Histologic Procedures in Engineered Heart Tissue
10.5 Representative Tissue Culture Study |
| 第13週 |
11.0 Tissue-Engineered Blood Vessels and Bones
11.1 Culture of Tissue-Engineered Vascular Grafts
11.2 Characterization of Engineered Vessels |
| 第14週 |
11.3 Isolation and Culture Methodology of hMSC for Tissue Engineering of Bone
11.4 Analytical and Histological Assays of Tissue-Engineered Bones |
| 第15週 |
Final Oral Presentation |
| 第16週 |
Final Oral Presenation |
自主學習
內容 |
02.閱覽產業及學術相關多媒體資料
03.製作專題報告
|